尽管最近抗青光眼技术有所改进,但新生血管性青光眼的处理仍是个棘手问题。作者曾报告8例应用Supramid植入技术治疗的初步结果,其中7例已随诊数年。本文将描述这些病例,并报告另9例的结果。方法:作者对16例有残余视力的新生血管性青光眼进行了研究。其中13例继发于视网膜中央静脉阻塞,2例继发于外伤,1例虹膜红变继发于长期未能控制的先天性青光眼,均以最大剂量的药物治疗而未能控制眼压。 Despite the recent improvements in anti-glaucoma technology, the management of neovascular glaucoma remains a thorny issue. The authors have reported the initial results of 8 cases treated with Supramid implants, of which 7 cases have been followed for several years. This article will describe these cases and report the results of another nine cases. Methods: The authors studied 16 cases of neovascular glaucoma with residual vision. Of these, 13 were secondary to central retinal vein occlusion, 2 were secondary to trauma, and 1 was iris redistribution secondary to long-term uncontrollable congenital glaucoma, both of which failed to control intraocular pressure with maximum dose of medication.